Register information Patent

DE file number : 60 2011 050 223.9 (Status: pending/in force, Query started: May 23, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 050 223.9
96EP file numberEAKZ11 81 6882.2
86WO file numberWAKZPCT/US2011/046957
97EP publication numberEPN2603514
87WO publication numberWPN2012021455
54Designation/titleTIZYKLISCHE BORONSÄUREESTERDERIVATE UND THERAPEUTISCHE VERWENDUNGEN DAVON
51IPC main classICM
(ICMV)
C07F 5/02 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/69 (2006.01), A61P 31/04 (2006.01)
22DE application dateDATAug 8, 2011
96EP application dateEATAug 8, 2011
86WO application dateWATAug 8, 2011
43Date of first publicationOTFeb 16, 2012
Date of publication of grantPETJul 18, 2018
71/73Applicant/ownerINHMelinta Therapeutics, Inc., 07960 Morristown, NJ, US
72InventorINHIRST, Gavin, San Diego, CA 92130, US; REDDY, Raja, San Diego, CA 92130, US; HECKER, Scott, Del Mar, CA 92014, US; TOTROV, Maxim, San Diego, CA 92103, US; GRIFFITH, David, C., San Marcos, CA 92069, US; RODNY, Olga, Mill Valley, CA 94941, US; DUDLEY, Michael, N., San Diego, CA 92127, US; BOYER, Serge, San Diego, CA 92109, US
74RepresentativeVTRAbitz & Partner Patentanwälte mbB, 81925 München, DE
Address for service Abitz & Partner Patentanwälte mbB, 81628 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161488655 P
May 20, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
372296 P
Aug 10, 2010
Due dateFT
FG
Aug 31, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
21File number of protection certificateZAKZ12 2019 000 027.5
12 2019 000 026.7
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002603514
Searchable text: EP000002603514
Original document: EP000002603514B1
Searchable text: EP000002603514B1
Original document: WO002012021455
Searchable text: WO002012021455
43Date of first publicationEVTFeb 16, 2012
Date of the first transfer into DPMAregisterEREGTAug 2, 2013
Date of the (most recent) update in DPMAregisterREGTSep 6, 2024
(Show all update days)(Hide all update days)
  • Sep 6, 2024
    • Due date: changed
  • Jul 20, 2024
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 16.02.2012: deleted
  • Sep 12, 2023; Sep 2, 2022; Sep 3, 2021; Aug 7, 2021; Aug 3, 2020; Jul 9, 2020; Jun 5, 2020; Aug 21, 2019; Aug 1, 2019; Jul 11, 2019; Jun 6, 2019; May 2, 2019; Feb 21, 2019; Dec 20, 2018; Nov 15, 2018; Oct 19, 2018; Oct 10, 2018; Aug 9, 2018; Jul 6, 2018; Jul 5, 2018; Jun 21, 2018; Feb 8, 2018
    • Historical data not available for this/these date(s)
  • Aug 2, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Feb 16, 2012  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Jun 19, 2013  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 1, 2013 Aug 1, 2013 Details anzeigen
4 Change of classification Change of IPC main class Sep 22, 2014  Details anzeigen
5 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jul 18, 2018  Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant Aug 9, 2018 Aug 9, 2018 Details anzeigen
7 New applicant/owner details New applicant/owner details Nov 14, 2018 Dec 20, 2018 Details anzeigen
8 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Apr 23, 2019 Jul 11, 2019 Details anzeigen
9 New applicant/owner details New applicant/owner details Jun 4, 2020 Jul 16, 2020 Details anzeigen
10 New applicant/owner details New applicant/owner details Aug 6, 2021 Sep 16, 2021 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTFeb 16, 2012
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJun 19, 2013
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 1, 2013
Issue numberHN31
YearPJ2013
Publication dateVTAug 1, 2013
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTSep 22, 2014
51IPC main classICM
(ICMV)
C07F 5/02 (2006.01)
51Previous IPC main classICMF
(ICMVF)
C07F 5/02 (2006.01)
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJul 18, 2018
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTAug 9, 2018
Issue numberHN32
YearPJ2018
Publication dateVTAug 9, 2018
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 14, 2018
Issue numberHN51
YearPJ2018
Publication dateVTDec 20, 2018
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHRempex Pharmaceuticals, Inc., Lincolnshire, IL, US
71/73Previous applicant/ownerINHFRempex Pharmaceuticals, Inc., San Diego, Calif., US
View procedures Procedure relating to EP application (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTApr 23, 2019
Issue numberHN28
YearPJ2019
Publication dateVTJul 11, 2019
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 4, 2020
Issue numberHN29
YearPJ2020
Publication dateVTJul 16, 2020
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMelinta Therapeutics, Inc., Morristown, NJ, US
71/73Previous applicant/ownerINHFRempex Pharmaceuticals, Inc., Lincolnshire, IL, US
Date of update of the procedureREGTJul 9, 2020
View procedures New applicant/owner details (No.: 10)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 6, 2021
Issue numberHN37
YearPJ2021
Publication dateVTSep 16, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMelinta Therapeutics, Inc., 07960 Morristown, NJ, US
71/73Previous applicant/ownerINHFMelinta Therapeutics, Inc., Morristown, NJ, US
Date of update of the procedureREGTSep 3, 2021